175 related articles for article (PubMed ID: 8181885)
21. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
[TBL] [Abstract][Full Text] [Related]
22. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
[TBL] [Abstract][Full Text] [Related]
23. The molecular markers of hemostatic activation on coronary artery disease.
Ulutin T; Sönmez H; Uçişik N; Süer S; Bayram C; Kökoglu E; Sultuybek G
Thromb Res; 1997 Nov; 88(3):329-32. PubMed ID: 9526953
[TBL] [Abstract][Full Text] [Related]
24. Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain.
Douglas JT; Lowe GD; Forbes CD; Prentice CR
Thromb Haemost; 1983 Aug; 50(2):541-2. PubMed ID: 6195751
[TBL] [Abstract][Full Text] [Related]
25. Hemostasis activation markers in acute renal failure.
Stefanidis I; Frank D; Maurin N
Ren Fail; 1998 Jan; 20(1):147-55. PubMed ID: 9509568
[TBL] [Abstract][Full Text] [Related]
26. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
[TBL] [Abstract][Full Text] [Related]
27. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
[TBL] [Abstract][Full Text] [Related]
28. Platelet hyperaggregability persists even after the improvement of increased blood coagulation and impaired fibrinolysis with the stabilization of symptoms in patients with unstable angina.
Miyamoto S; Ogawa H; Sakamoto T; Soejima H; Takazoe K; Shimomura H; Kajiwara I; Yoshimura M; Kugiyama K; Nakamura S; Ozaki Y
Int J Cardiol; 2001; 80(2-3):235-42. PubMed ID: 11578720
[TBL] [Abstract][Full Text] [Related]
29. Absence of a prothrombotic state in restenotic patients?
Brack MJ; More RS; Pringle S; Gershlick AH
Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
[TBL] [Abstract][Full Text] [Related]
30. Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium.
Munkvad S; Jespersen J; Gram J; Kluft C
J Intern Med; 1990 Oct; 228(4):361-6. PubMed ID: 1702458
[TBL] [Abstract][Full Text] [Related]
31. Coagulation system activity before coronary artery bypass surgery for unstable angina.
Bjessmo S; Ivert T; Egberg N
Scand Cardiovasc J; 2001 Sep; 35(4):280-4. PubMed ID: 11759123
[TBL] [Abstract][Full Text] [Related]
32. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
Mossard JM; Wiesel ML; Cazenave JP; Grunebaum L; Drawin T; Kieny JR; Roul G; Bareiss P; Sacrez A
Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1813-8. PubMed ID: 2514633
[TBL] [Abstract][Full Text] [Related]
33. Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss.
Wagner WR; Johnson PC; Thompson KA; Marrone GC
Ann Thorac Surg; 1994 Sep; 58(3):734-40; discussion 741. PubMed ID: 7944696
[TBL] [Abstract][Full Text] [Related]
34. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
[TBL] [Abstract][Full Text] [Related]
35. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
36. Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease.
Smith FB; Lowe GD; Fowkes FG; Rumley A; Rumley AG; Donnan PT; Housley E
Atherosclerosis; 1993 Sep; 102(2):155-62. PubMed ID: 8251001
[TBL] [Abstract][Full Text] [Related]
37. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation.
Heppell RM; Berkin KE; McLenachan JM; Davies JA
Heart; 1997 May; 77(5):407-11. PubMed ID: 9196408
[TBL] [Abstract][Full Text] [Related]
38. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
[TBL] [Abstract][Full Text] [Related]
39. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
[TBL] [Abstract][Full Text] [Related]
40. Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris.
Vaziri ND; Kennedy SC; Kennedy D; Gonzales E
Am J Med; 1992 Dec; 93(6):651-7. PubMed ID: 1466361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
